Oct 22, 2025 · Herceptin (trastuzumab) can be an effective treatment both before and after surgery for people with HER2-positive breast cancer. Learn more.

Summary Background Trastuzumab targets the extracellular domain of the HER2 protein. Adding trastuzumab to chemotherapy for patients with early-stage, HER2-positive breast cancer …

Jun 19, 2024 · The topic of whether HER2+ status in breast cancer (BC) contributes to disease recurrence and survival has long been settled, leading to the advent of HER2-targeting agents …

Sep 17, 2025 · Studies show trastuzumab can shrink tumors and improve survival in people with HER2-positive metastatic breast cancer. Trastuzumab is effective as a first treatment for …

1 day ago · The efficacy and safety of trastuzumab deruxtecan in patients with no previous therapy for HER2-positive advanced or metastatic breast cancer are unclear.

Apr 15, 2024 · Find out all you need to know about Herceptin (trastuzumab) for early and more advanced HER2-positive breast cancer, including what to expect, outcomes, side effects, and …

Oct 19, 2025 · Trastuzumab rezetecan significantly reduced disease progression risk by 78% compared to pyrotinib plus capecitabine in HER2-positive advanced breast cancer patients. …

Trastuzumab (Herceptin) is a targeted therapy for treating breast cancer. Find out when it's used, how it works and possible side effects.

Nov 7, 2024 · Herceptin, a HER2 inhibitor targeted therapy, treats breast cancer. Learn if it's right for you and more here.

Explore the implications of long-term Herceptin use for HER2-positive breast cancer. Understand benefits, risks, guidelines, and ongoing research. 💊🌸